Examkin

Soru

Zorluk: OrtaNephrology

A 6464-year-old man comes to the clinic for a routine follow-up. He has a 1515-year history of type 2 diabetes mellitus, hypertension, and hyperlipidemia. His current medications include lisinopril, amlodipine, atorvastatin, and insulin glargine. Blood pressure is 138/86 mm Hg138/86 \text{ mm Hg}, and pulse is 76/min76\text{/min}. Physical examination reveals decreased sensation to monofilament testing in the bilateral feet. Laboratory studies show the following:

ParameterResult
Serum sodium139 mEq/L139 \text{ mEq/L}
Serum potassium5.6 mEq/L5.6 \text{ mEq/L}
Serum chloride109 mEq/L109 \text{ mEq/L}
Serum bicarbonate18 mEq/L18 \text{ mEq/L}
Blood urea nitrogen32 mg/dL32 \text{ mg/dL}
Serum creatinine1.9 mg/dL1.9 \text{ mg/dL}
Urine pH5.25.2

Which of the following is the most likely primary mechanism responsible for this patient's laboratory findings?

  1. Decreased production of and tubular responsiveness to aldosteroneCevap
  2. B
    Impaired proximal tubular reabsorption of filtered bicarbonate
  3. C
    Inability of distal intercalated cells to secrete hydrogen ions
  4. D
    Accumulation of unmeasured endogenous organic acids
  5. E
    Excessive loss of bicarbonate from the gastrointestinal tract

Cevap

Decreased production of and tubular responsiveness to aldosterone
The correct answer identifies the underlying pathophysiology of Type 4 Renal Tubular Acidosis (RTA). This patient presents with a metabolic acidosis (low bicarbonate of 18 mEq/L18 \text{ mEq/L}) and a normal anion gap of 12 mEq/L12 \text{ mEq/L}. The presence of hyperkalemia (5.6 mEq/L5.6 \text{ mEq/L}) in the setting of a normal anion gap metabolic acidosis points to a defect in aldosterone secretion or action (Type 4 RTA). In patients with long-standing diabetes, damage to the juxtaglomerular apparatus leads to a state of hyporeninemic hypoaldosteronism. Additionally, the patient is taking an ACE inhibitor (lisinopril), which further blunts aldosterone production. Without adequate aldosterone effect at the distal tubule, there is impaired secretion of both potassium and hydrogen ions, resulting in hyperkalemia and mild metabolic acidosis. The kidneys retain the ability to acidify the urine in Type 4 RTA, which is reflected in the appropriately low urine pH (5.25.2).

Adım Adım Çözüm

1
Calculate the serum anion gap.
Anion Gap = Na+−(Cl−+HCO3−)=139−(109+18)=12 mEq/L\text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) = 139 - (109 + 18) = 12 \text{ mEq/L}.
Determining the anion gap is the first step in classifying any metabolic acidosis. A normal gap (8−12 mEq/L8-12 \text{ mEq/L}) narrows the differential to hyperchloremic metabolic acidosis (NAGMA).
2
Evaluate the serum potassium level in the context of NAGMA.
The patient has hyperkalemia (5.6 mEq/L5.6 \text{ mEq/L}).
In NAGMA, the potassium level helps differentiate the etiology. Hypokalemia suggests GI losses (diarrhea) or Type 1 / Type 2 RTA. Hyperkalemia strongly points to Type 4 RTA.
3
Synthesize the clinical context and remaining lab values.
The patient has a hyperkalemic NAGMA with an acidic urine (pH 5.25.2) in the setting of long-standing diabetes and ACE inhibitor use.
Diabetic nephropathy damages the juxtaglomerular apparatus, reducing renin and aldosterone. Lisinopril further inhibits aldosterone. The resulting hypoaldosteronism impairs distal potassium and hydrogen secretion, causing Type 4 RTA.

Anahtar Kavram

Diagnosis and pathophysiology of Type 4 Renal Tubular Acidosis (hyporeninemic hypoaldosteronism).
Bu soruyu puanla

Konular

Nephrology

Bu konudan daha fazla soru